Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AAT (Alimenti a Tecnologia Avanzata) is an Italian biotechnology company and contract research organization (CRO) specializing in the study of the gut microbiota and the development of probiotics and functional foods. Founded as a spin-off from the Università Cattolica del Sacro Cuore, the company provides comprehensive research services including microbial characterization, in vitro modeling, and the design of clinical trials for food supplements. AAT supports pharmaceutical and food companies in validating the efficacy and safety of probiotic strains and bioactive compounds. Their expertise spans from genomic analysis of bacteria to the evaluation of host-microbe interactions in various health contexts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Italy AAT.